Exact Mass: 613.3098102
Exact Mass Matches: 613.3098102
Found 178 metabolites which its exact mass value is equals to given mass value 613.3098102
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ferrioxamine B
Ferrioxamine b belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Ferrioxamine b is considered to be a practically insoluble (in water) and relatively neutral molecule. Ferrioxamine b exists in all living organisms, ranging from bacteria to humans.
3beta-hydroxynorerythrosuamine 3-O-beta-D-glucopyranoside hydrochloride
(1alpha,6alpha,14alpha)-8-acetoxy-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 4-methoxybenzoate|macrorhynine B
C33H43NO10 (613.2886818000001)
CID 154831998
Glu Phe Arg Tyr
Glu Phe Tyr Arg
Glu Arg Phe Tyr
Glu Arg Tyr Phe
Glu Tyr Phe Arg
Glu Tyr Arg Phe
Phe Glu Arg Tyr
Phe Glu Tyr Arg
Phe Arg Glu Tyr
Phe Arg Tyr Glu
Phe Val Trp Tyr
C34H39N5O6 (613.2900193999999)
Phe Val Tyr Trp
C34H39N5O6 (613.2900193999999)
Phe Trp Val Tyr
C34H39N5O6 (613.2900193999999)
Phe Trp Tyr Val
C34H39N5O6 (613.2900193999999)
Phe Tyr Glu Arg
Phe Tyr Arg Glu
Phe Tyr Val Trp
C34H39N5O6 (613.2900193999999)
Phe Tyr Trp Val
C34H39N5O6 (613.2900193999999)
Ile Arg Tyr Tyr
Ile Tyr Arg Tyr
Ile Tyr Tyr Arg
Leu Arg Tyr Tyr
Leu Tyr Arg Tyr
Leu Tyr Tyr Arg
Pro Arg Arg Trp
C28H43N11O5 (613.3448467999999)
Pro Arg Trp Arg
C28H43N11O5 (613.3448467999999)
Pro Trp Arg Arg
C28H43N11O5 (613.3448467999999)
Arg Glu Phe Tyr
Arg Glu Tyr Phe
Arg Phe Glu Tyr
Arg Phe Tyr Glu
Arg Ile Tyr Tyr
Arg Leu Tyr Tyr
Arg Pro Arg Trp
C28H43N11O5 (613.3448467999999)
Arg Pro Trp Arg
C28H43N11O5 (613.3448467999999)
Arg Arg Pro Trp
C28H43N11O5 (613.3448467999999)
Arg Arg Trp Pro
C28H43N11O5 (613.3448467999999)
Arg Trp Pro Arg
C28H43N11O5 (613.3448467999999)
Arg Trp Arg Pro
C28H43N11O5 (613.3448467999999)
Arg Tyr Glu Phe
Arg Tyr Phe Glu
Arg Tyr Ile Tyr
Arg Tyr Leu Tyr
Arg Tyr Tyr Ile
Arg Tyr Tyr Leu
Val Phe Trp Tyr
C34H39N5O6 (613.2900193999999)
Val Phe Tyr Trp
C34H39N5O6 (613.2900193999999)
Val Trp Phe Tyr
C34H39N5O6 (613.2900193999999)
Val Trp Tyr Phe
C34H39N5O6 (613.2900193999999)
Val Tyr Phe Trp
C34H39N5O6 (613.2900193999999)
Val Tyr Trp Phe
C34H39N5O6 (613.2900193999999)
Trp Phe Val Tyr
C34H39N5O6 (613.2900193999999)
Trp Phe Tyr Val
C34H39N5O6 (613.2900193999999)
Trp Pro Arg Arg
C28H43N11O5 (613.3448467999999)
Trp Arg Pro Arg
C28H43N11O5 (613.3448467999999)
Trp Arg Arg Pro
C28H43N11O5 (613.3448467999999)
Trp Val Phe Tyr
C34H39N5O6 (613.2900193999999)
Trp Val Tyr Phe
C34H39N5O6 (613.2900193999999)
Trp Tyr Phe Val
C34H39N5O6 (613.2900193999999)
Trp Tyr Val Phe
C34H39N5O6 (613.2900193999999)
Tyr Glu Phe Arg
Tyr Glu Arg Phe
Tyr Phe Glu Arg
Tyr Phe Arg Glu
Tyr Phe Val Trp
C34H39N5O6 (613.2900193999999)
Tyr Phe Trp Val
C34H39N5O6 (613.2900193999999)
Tyr Ile Arg Tyr
Tyr Ile Tyr Arg
Tyr Leu Arg Tyr
Tyr Leu Tyr Arg
Tyr Arg Glu Phe
Tyr Arg Phe Glu
Tyr Arg Ile Tyr
Tyr Arg Leu Tyr
Tyr Arg Tyr Ile
Tyr Arg Tyr Leu
Tyr Val Phe Trp
C34H39N5O6 (613.2900193999999)
Tyr Val Trp Phe
C34H39N5O6 (613.2900193999999)
Tyr Trp Phe Val
C34H39N5O6 (613.2900193999999)
Tyr Trp Val Phe
C34H39N5O6 (613.2900193999999)
Tyr Tyr Ile Arg
Tyr Tyr Leu Arg
Tyr Tyr Arg Ile
Tyr Tyr Arg Leu
5-[4,5-DIHYDRO-5-OXO-3-[(1-OXOOCTADECYL)AMINO]-1H-PYRAZOL-1-YL]-2-PHENOXY-BENZENESULFONIC ACID
TAE684(NVP-TAE684)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Skinasensyl
C34H39N5O6 (613.2900193999999)
Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1]. Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1].
Aplaviroc hydrochloride
C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist
N-(Ethylsulfonyl)-5-propoxy-L-tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}-L-glutamamide
C29H39N7O6S (613.2682394000001)
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-(2-aminophenyl)-4-[[[(2R,3S)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(2S,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-(2-aminophenyl)-4-[[[(2R,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclohexanecarboxamide
C37H47N3O5 (613.3515531999999)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-(2-aminophenyl)-4-[[[(2R,3S)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-(2-aminophenyl)-4-[[[(2S,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
2-amino-3-[[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C30H48NO10P (613.3015677999999)
2-amino-3-[[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C30H48NO10P (613.3015677999999)
3-[[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
C30H48NO10P (613.3015677999999)
Ferroxamine
A Fe(III)-complexed hydroxamate siderophore comprising equimolar amounts of iron(3+) and desferrioxamine B(3-)
methyl (1r,2s,4ar,4bs,7e,8r,8as,9r,10ar)-9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1-carboxylate
3-(4-{15-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaen-1-ylidene}-1-methyl-3,5-dioxopyrrolidin-2-yl)propanoic acid
{2,12-dihydroxy-4-[3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-1,13-dimethyl-6-oxo-5,17-dioxabicyclo[14.1.0]heptadeca-7,14-dien-10-yl}acetic acid
(2s)-5-carbamimidamido-2-({[(2s)-1-[(2r)-2-{[(3s)-1,3-dihydroxy-7-methyloctylidene]amino}-3-(1h-indol-3-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)pentanoic acid
{11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid
C30H48NO10P (613.3015677999999)